290 related articles for article (PubMed ID: 28007570)
21. Brain molecules and appetite: the case of oleoylethanolamide.
Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
[TBL] [Abstract][Full Text] [Related]
22. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.
Fu J; Astarita G; Gaetani S; Kim J; Cravatt BF; Mackie K; Piomelli D
J Biol Chem; 2007 Jan; 282(2):1518-28. PubMed ID: 17121838
[TBL] [Abstract][Full Text] [Related]
23. Role of the satiety factor oleoylethanolamide in alcoholism.
Bilbao A; Serrano A; Cippitelli A; Pavón FJ; Giuffrida A; Suárez J; García-Marchena N; Baixeras E; Gómez de Heras R; Orio L; Alén F; Ciccocioppo R; Cravatt BF; Parsons LH; Piomelli D; Rodríguez de Fonseca F
Addict Biol; 2016 Jul; 21(4):859-72. PubMed ID: 26037332
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction.
Yang Y; Chen M; Georgeson KE; Harmon CM
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R235-41. PubMed ID: 16902188
[TBL] [Abstract][Full Text] [Related]
25. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.
Guijarro A; Fu J; Astarita G; Piomelli D
Pharmacol Res; 2010 Jan; 61(1):27-33. PubMed ID: 19778614
[TBL] [Abstract][Full Text] [Related]
26. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
[TBL] [Abstract][Full Text] [Related]
27. Role of oleoylethanolamide as a feeding regulator in goldfish.
Tinoco AB; Armirotti A; Isorna E; Delgado MJ; Piomelli D; de Pedro N
J Exp Biol; 2014 Aug; 217(Pt 15):2761-9. PubMed ID: 24855680
[TBL] [Abstract][Full Text] [Related]
28. Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism.
Igarashi M; Hayakawa T; Tanabe H; Watanabe K; Nishida A; Kimura I
Mol Metab; 2023 Jan; 67():101649. PubMed ID: 36462626
[TBL] [Abstract][Full Text] [Related]
29. The satiety factor oleoylethanolamide impacts hepatic lipid and glucose metabolism in goldfish.
Gómez-Boronat M; Velasco C; Isorna E; De Pedro N; Delgado MJ; Soengas JL
J Comp Physiol B; 2016 Dec; 186(8):1009-1021. PubMed ID: 27277972
[TBL] [Abstract][Full Text] [Related]
30. Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity.
Baraghithy S; Smoum R; Drori A; Hadar R; Gammal A; Hirsch S; Attar-Namdar M; Nemirovski A; Gabet Y; Langer Y; Pollak Y; Schaaf CP; Rech ME; Gross-Tsur V; Bab I; Mechoulam R; Tam J
J Bone Miner Res; 2019 Jan; 34(1):93-105. PubMed ID: 30347474
[TBL] [Abstract][Full Text] [Related]
31. Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.
Bischof JM; Van Der Ploeg LH; Colmers WF; Wevrick R
Br J Pharmacol; 2016 Sep; 173(17):2614-21. PubMed ID: 27339818
[TBL] [Abstract][Full Text] [Related]
32. Impaired melanocortin pathway function in Prader-Willi syndrome gene-Magel2 deficient mice.
Oncul M; Dilsiz P; Ates Oz E; Ates T; Aklan I; Celik E; Sayar Atasoy N; Atasoy D
Hum Mol Genet; 2018 Sep; 27(18):3129-3136. PubMed ID: 29878108
[TBL] [Abstract][Full Text] [Related]
33. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.
Fu J; Kim J; Oveisi F; Astarita G; Piomelli D
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R45-50. PubMed ID: 18434444
[TBL] [Abstract][Full Text] [Related]
34. Abnormal response to the anorexic effect of GHS-R inhibitors and exenatide in male Snord116 deletion mouse model for Prader-Willi syndrome.
Lin D; Wang Q; Ran H; Liu K; Wang Y; Wang J; Liu Y; Chen R; Sun Y; Liu R; Ding F
Endocrinology; 2014 Jul; 155(7):2355-62. PubMed ID: 24735326
[TBL] [Abstract][Full Text] [Related]
35. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
[TBL] [Abstract][Full Text] [Related]
36. Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome.
Bischof JM; Wevrick R
Mol Genet Metab; 2018 Apr; 123(4):511-517. PubMed ID: 29506955
[TBL] [Abstract][Full Text] [Related]
37. FAAH deficiency promotes energy storage and enhances the motivation for food.
Touriño C; Oveisi F; Lockney J; Piomelli D; Maldonado R
Int J Obes (Lond); 2010 Mar; 34(3):557-68. PubMed ID: 20029375
[TBL] [Abstract][Full Text] [Related]
38. Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty.
Fountain MD; Tao H; Chen CA; Yin J; Schaaf CP
Genes Brain Behav; 2017 Jul; 16(6):592-600. PubMed ID: 28296079
[TBL] [Abstract][Full Text] [Related]
39. The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice.
Caillon A; Duszka K; Wahli W; Rohner-Jeanrenaud F; Altirriba J
Metabolism; 2018 Oct; 87():13-17. PubMed ID: 29936173
[TBL] [Abstract][Full Text] [Related]
40. Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus).
Astarita G; Rourke BC; Andersen JB; Fu J; Kim JH; Bennett AF; Hicks JW; Piomelli D
Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1407-12. PubMed ID: 16373434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
